Apremilast for Recalcitrant Erythema Nodosum: A Case Series

Key Points

• Apremilast demonstrates efficacy in reducing symptoms of erythema nodosum, showing a notable improvement in patient skin conditions.
• The case series indicates positive responses to apremilast treatment, providing crucial insights for future management strategies.
• Observational analysis involved multiple cases with varying responses to apremilast, highlighting the drug's potential benefits.
• Further external validation is essential to generalize findings beyond this case series, considering individual variability.

Abstract